-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Initiates Coverage On Carlsmed with Buy Rating, Announces Price Target of $17

Benzinga·07/01/2026 11:56:28
Listen to the news
Needham analyst David Saxon initiates coverage on Carlsmed (NASDAQ:CARL) with a Buy rating and announces Price Target of $17.